PHOENIX, Arizona — Patients treated with radiofrequency intradiscal biacuplasty (IDB) for discogenic low back pain show maintenance of improvements in pain and physical function for as long as a year ...

Vivex Biologics, a leader in developing and delivering innovative allografts, today announced the publication of a new real-world evidence study demonstrating that VIA Disc® NP significantly reduces ...

Discogenic pain originates from structural and biochemical changes in the nucleus pulposus, a gel-like disc component responsible for maintaining disc height and absorbing mechanical stress.

In a recent study published in Biomaterials, researchers developed a novel non-viral gene therapy for discogenic back pain (DBP) by delivering a developmental-type transcription factor, Forkhead Box ...

BioRestorative Therapies, Inc. announced that the FDA has cleared its Investigational New Drug application for BRTX-100, marking it as the first stem cell product candidate approved for evaluation in ...